par Gouvêa Bogossian, Elisa 
;Taccone, Fabio
Référence Current opinion in critical care, 28, 2, page (130-137)
Publication Publié, 2022-04-01
;Taccone, Fabio Référence Current opinion in critical care, 28, 2, page (130-137)
Publication Publié, 2022-04-01
Article révisé par les pairs
| Résumé : | Purpose of reviewFever is common after acute brain injury and is associated with poor prognosis in this setting.Recent findingsAchieving normothermia is feasible in patients with ischemic or hemorrhagic stroke, subarachnoid hemorrhage and traumatic brain injury. Pharmacological strategies (i.e. paracetamol or nonsteroidal anti-inflammatory drugs) are frequently ineffective and physical (i.e. cooling devices) therapies are often required. There are no good quality data supporting any benefit from therapeutic strategies aiming at normothermia in all brain injured patients when compared with standard of care, where mild-to-moderate fever is tolerated. However, recent guidelines recommended fever control in this setting.SummaryAs fever is considered a clinically relevant secondary brain damage, we have provided an individualized therapeutic approach to treat it in brain injured patients, which deserved further validation in the clinical setting. |
